losmapimod
losmapimod: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Fulcrum Therapeutics, Inc. (FULC) | Phase 3 |
Clinical Trials (1)
A Phase 3 Global, Randomized, Double-Blind, Placebo-Controlled, 48-Week, Parallel-Group Study of the Efficacy and Safety of Losmapimod in Treating Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH)
Frequently asked questions
Who is developing losmapimod?
losmapimod is being developed by Fulcrum Therapeutics, Inc..
How many clinical trials involve losmapimod?
BioSniper tracks 1 clinical trial involving losmapimod.
Get deeper analysis on losmapimod
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis